← SynDRA
VIDARABINE
SynDRA canonical compound SYN0003656 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Primary target(s) | ADA |
|---|
| Mechanism of action | Antiviral |
|---|
| Indication | varicella-zoster virus (VZV) | virus herpes simplex (HSV) |
|---|
| Disease area | infectious disease |
|---|
All known targets
- ADA
- ADCY5
- ADORA2B
- Adcy5
- Ahcy
- DCK
- DGUOK
- DPP4
- POLA1
- PRPS1
- RRM1
- RRM2
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- TK1
- GMNN
- HDAC6
- SAMHD1
- SLCO1B1
- SLCO1B3
- TDP1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Anti-Infective Agents
- Antimetabolites
- Antiviral Agents
- Noxae
- Antiviral
ATC classes
- S01A · ANTIINFECTIVES
- J05A · DIRECT ACTING ANTIVIRALS
Cross-references
Synonyms
- VIRA-A
- vidarabine anhydrous
- adenine arabinoside
- araadenosine
- arabinosyladenine
- vidarabin
- Vidarabina
- Vidarabine monohydrate
- Arabinosyladenine
- Arasena-a
- Vidarabine anhydrous
- Vidarabine, anhydrous
- ARA-A
- CI-673
- NSC-247519
- NSC-404241
- NSC-757383
- Vira-a
- Araadenosine
- Armes
- RAB
- Spongoadenosine
- VIRDARABINE
- Vidarabin
- Vidarabinum
- Xylosyladenine
- Adenine arabinoside
- Adenine xyloside
- Adenosine arabinose
- Ara-A
- Arabinoside adenine
- Arabinosyl-adenine
- Vidarabina [DCIT]
- Vira ATM
- Xylosyl A
- A 9251
- ARA-A NSC 247519
- Alpha-Ara A
Look up VIDARABINE in the interactive SynDRA portal →